Engineering and Development

Management and Executive

Legal and Compliance

Product Management

Customer Service and Support

Sales

Accounting and Finance

Marketing

Chairman & CEO

Executive Vice President & Chief Regulatory Officer

Infectious Disease Diagnostics Market worth US$42.20 billion by 2030 with 9.7% CAGR | MarketsandMarkets™

Point of Care Molecular Diagnostics Market worth US$7.09 billion by 2030 with 10.5% CAGR | MarketsandMarkets™

Cepheid Receives Health Canada Licence for Xpert® HCV VL Fingerstick

Press Release Biocartis NV: Biocartis Welcomes Mike Kreitzinger as Senior Vice President of Global Business Development

Senior Manager of Global Strategy

Cepheid, a Danaher operating company, is committed to improving healthcare through innovative molecular diagnostic systems. The Senior Manager of Global Strategy will support the development of a top-level strategy for Cepheid, driving research and analyses to inform strategic decision-making across various domains, including product prioritization and commercialization.

Sign up with Google

Sign in with Google